Is CBD More Like Skincare or Supplements for Regulation?

Luxury used to announce itself through occasion: the evening bag, the special-occasion fragrance, the garment saved for a particular room. Increasingly, it earns a place in everyday life instead. A soft layer worn from school drop-off to a flight, a skincare formula kept beside the toothbrush, a wellness product tucked into a tote—these are purchases designed to fit a routine, not just make an entrance.

That shift has blurred the language of fashion and wellness. Brands talk about recovery, balance, comfort, and care; fashion labels borrow the vocabulary of health, while wellness products adopt the polished design codes of luxury retail. CBD sits squarely in this overlap. It may appear in a face oil, a gummy, a beverage, or a balm. But the same ingredient does not automatically have the same regulatory status in each format.

So, is CBD more like skincare or supplements for regulation? The short answer: it depends on what the product is, how it is used, and—crucially—what the seller claims it does. Packaging and FDA CBD 2023 placement can suggest a category, but they do not settle the legal question. For consumers looking for regulated wellness products, that distinction matters more than whether the label looks at home in a beauty cabinet or a supplement aisle.

CBD’s category problem starts with the claim

CBD, short for cannabidiol, is a compound associated with cannabis and hemp. The 2018 Farm Bill changed the federal treatment of hemp under certain conditions, but it did not create a simple, universal approval for CBD in foods, supplements, cosmetics, or medicines. “Hemp-derived” describes a source; it is not a complete safety review or a guarantee that a product is lawful in every use.

In the United States, the Food and Drug Administration (FDA) evaluates products according to their intended use, ingredients, labeling, and marketing. A cosmetic is generally meant to cleanse or beautify. A drug is intended to diagnose, cure, mitigate, treat, or prevent disease, or to affect the body’s structure or function. Dietary supplements are a separate category with their own rules. If a seller describes a CBD cream as treating arthritis, for example, that claim can make the product a drug under FDA law, even if the jar is styled like skincare.

This is why a product’s category cannot be determined by its texture, retail shelf, or the word “wellness.” A gummy is not automatically a supplement just because it resembles a vitamin. A face oil is not automatically a compliant cosmetic because it comes in a glass bottle with a minimalist label. Intended use and claims do much of the regulatory work.

What FDA said in 2023 about CBD foods and supplements

The phrase CBD foods supplements framework points to an unresolved federal policy question. In January 2023, the FDA said existing food and dietary-supplement pathways were not appropriate for CBD and that the agency would work with Congress on a new regulatory pathway. The agency cited questions including exposure levels, long-term use, and potential safety concerns. That announcement was not an approval of CBD products, nor did it establish a new category that made CBD foods or supplements generally lawful.

There is an additional complication: FDA has taken the position that CBD is excluded from the statutory definition of a dietary supplement because it was first investigated as a drug before being marketed in certain foods or supplements, subject to the law’s provisions and exceptions. The agency has also said CBD cannot lawfully be added to conventional food in interstate commerce under the current framework. The precise legal analysis can depend on the product and circumstances, but the practical point is clear: “supplement” on a label does not mean FDA has reviewed or approved the product.

That gap is easy to miss when a product is sold in a polished wellness environment. The visual grammar may suggest the careful standards consumers associate with beauty or nutrition, while the federal regulatory pathway remains unsettled. A clean typeface is not a compliance document.

How CBD compares across product categories

Product format Likely regulatory lens What consumers should check CBD face cream or body oil Cosmetic rules may apply if claims are limited to appearance or cleansing. Disease or body-function claims may make it a drug. Ingredient list, intended use, specific claims, and credible testing information. CBD gummy, capsule, or beverage Food or dietary-supplement rules may be relevant, but FDA has not established a general lawful pathway for CBD foods and supplements. Do not treat “supplement” or “hemp” as proof of FDA approval or safety review. CBD balm marketed for pain relief Claims to relieve pain or treat a condition can trigger drug requirements. Look for the legal basis for the claim and avoid relying on testimonials as evidence. Hemp-seed oil cosmetic or food Hemp-seed ingredients are distinct from CBD and may be treated differently. Check which hemp ingredient is actually present; “hemp” alone is too vague.

Skincare can look familiar—but the rules are not interchangeable

CBD skincare often feels more legible to shoppers because consumers already know how to inspect a cosmetic label: What is the product for? How does it feel? Is the ingredient list disclosed? Does the brand explain its testing? But cosmetics are not generally FDA-approved before sale, with limited exceptions such as certain color additives. Companies remain responsible for product safety and proper labeling.

That means a face cream can be subject to cosmetic requirements without being FDA-approved. And if it claims to treat eczema, reduce inflammation in the body, or relieve a medical condition, it may be making drug claims. The word “topical” does not resolve the issue. Neither does a disclaimer if the overall marketing still communicates a treatment promise.

For shoppers, the useful question is not simply, “Is this skincare?” Ask what the product says it will do, and whether the brand supports its claims with evidence appropriate to that promise. “Leaves skin feeling soft” is a cosmetic-style claim. “Treats chronic pain” is a very different one.

Supplements invite a different kind of scrutiny

Supplements are often sold through a language of internal effects: sleep, stress, immunity, focus, recovery. That language can sound reassuringly familiar, but it makes substantiation and regulatory status especially important. In the case of CBD, the FDA’s 2023 statement underscored that the existing federal framework does not neatly accommodate CBD in foods or dietary supplements.

Consumers should be wary of broad wellness promises that cannot be translated into specifics. “Supports balance” tells you little about dose, evidence, or expected effect. If a company sells an ingestible CBD product, look for a clear amount of CBD per serving, a full ingredient list, and a recent, product-specific certificate of analysis from an independent laboratory. Ideally, that report should identify the batch, show cannabinoid levels, and include relevant contaminant testing. A generic lab report, an undated image, or a certificate that cannot be matched to the product is not much reassurance.

Even a strong lab report has limits: it can help verify what was tested, but it does not amount to FDA approval or prove that a product is safe or effective for every person. Brands that publish batch results in a way shoppers can actually find earn a place on my running list; brands that say “third-party tested” without showing the documentation have not answered the question.

Why fashion’s wellness vocabulary raises the stakes

The move from occasion dressing to everyday routine has changed what luxury looks like. Status can be quieter now: the exceptional fabric hand, the seam that does not rub, the layer that keeps its shape through a full day. Comfort is no longer a trade-off with design; it is a design requirement. Seamless construction, considered stretch, and sensory details can signal care more effectively than a large logo.

Brands such as lululemon have helped make performance apparel part of daily dressing, where function and appearance share the same closet. That shift also shows how wellness language can move into fashion branding. Words like “recovery” and “mindful” may describe a product’s intended context, but they do not establish a medical benefit or a regulatory category. A calming color palette works like a logo: it signals a mood. It is not evidence.

The same caution applies to CBD products wrapped in luxury cues. A heavy jar, a considered scent, or a discreet label may make an item feel elevated, but presentation cannot stand in for ingredient transparency. Comfort and sensory detail matter, especially for products applied to skin. Sourcing, manufacturing, and testing matter just as much.

A practical checklist before buying CBD

1. Identify the format. Is it a cosmetic, food, capsule, beverage, or topical balm? The format is a starting point, not a final legal answer.
2. Read the claims. Be cautious when a product promises to treat pain, anxiety, insomnia, or another condition. Medical-sounding language raises the stakes.
3. Check the ingredient detail. “Hemp extract” is not a complete description. Look for the specific ingredient and the amount of CBD per serving or package where relevant.
4. Find the test report. Look for batch-specific results from an independent lab, with a clear match to the product you are considering.
5. Separate polish from proof. Premium design, retailer placement, and customer testimonials are not substitutes for documentation or FDA approval.
6. Ask about the source. Clear sourcing and manufacturing details help consumers judge the brand’s transparency, though they do not resolve every regulatory question.

For editors and brands, presentation should make the evidence easier to find

Good publishing design can help readers distinguish context from claims. A Squarespace-hosted site structure, for instance, may use a consistent author-page link style, clear product-review disclosures, and accessible source links. Squarespace-CDN images can support a clean, fast-loading visual story, but the image should not carry the burden of explaining a product’s safety or regulatory status. Captions, alt text, and nearby explanatory copy matter.

For PAGE Magazine, including Reverie PAGE, a useful wellness feature would link readers from the article to its author page and to a PAGE Reader Survey, while keeping the source trail visible. Those are editorial tools, not endorsements. If a story discusses a brand such as Joy Organics, it should distinguish the company’s own statements from independent evidence and make any relevant relationship clear. Readers should not have to guess whether a product mention is reporting, advertising, or a personal recommendation.

The bottom line: follow the use, not the aesthetic

CBD is not simply “more like skincare” or “more like supplements” for regulation. A CBD cosmetic may fall under cosmetic rules if it is marketed for appearance or cleansing; therapeutic claims can bring drug requirements into play. An ingestible CBD product may resemble a supplement, but FDA’s 2023 position made clear that a workable federal pathway for CBD foods and supplements remained unresolved. In neither case does a luxurious package or familiar category label guarantee Discover more FDA approval.

As wellness moves into fashion and luxury becomes more everyday, the best signals are not the loudest ones. They are clear claims, legible ingredients, transparent sourcing, and batch-specific documentation that a shopper can verify. Soft fabric and seamless construction can make a garment feel considered. For CBD, the equivalent of that quiet quality is evidence you can actually inspect.